Panel Discussion: Reformulating LNPs to Achieve Extrahepatic Delivery & Expand Therapeutic Reach

• Which extrahepatic targets remain the greatest unmet clinical need?
• What are the inherent biological challenges that are limiting  LNPs from moving beyond the liver?
• How to better leverage formulation and administration routes to  enable effective extrahepatic targeting?

Speakers:

Amit Singh

Director, Delivery Discovery

Mote Therapeutics

Daryl Drummond

Chief Scientific Officer

Akagera Medicines

Ester Caffarel-Salvador

Director, Strategic Innovation, Global Rare Disease

Chiesi Global Rare Diseases